3.425
price up icon1.65%   0.085
after-market Handel nachbörslich: 3.42 -0.005 -0.15%
loading
Schlusskurs vom Vortag:
$3.34
Offen:
$3.37
24-Stunden-Volumen:
454.12K
Relative Volume:
0.89
Marktkapitalisierung:
$1.07B
Einnahmen:
$563.46M
Nettoeinkommen (Verlust:
$27.92M
KGV:
35.53
EPS:
0.0964
Netto-Cashflow:
$-146.33M
1W Leistung:
+3.51%
1M Leistung:
+0.44%
6M Leistung:
-34.08%
1J Leistung:
-66.97%
1-Tages-Spanne:
Value
$3.36
$3.485
1-Wochen-Bereich:
Value
$3.23
$3.485
52-Wochen-Spanne:
Value
$3.03
$11.85

Alvotech Stock (ALVO) Company Profile

Name
Firmenname
Alvotech
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,460
Name
Twitter
Name
Nächster Verdiensttermin
2026-05-06
Name
Neueste SEC-Einreichungen
Name
ALVO's Discussions on Twitter

Compare ALVO vs TAK, HLN, TEVA, ZTS, UTHR

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ALVO icon
ALVO
Alvotech
3.435 1.04B 563.46M 27.92M -146.33M 0.0964
TAK icon
TAK
Takeda Pharmaceutical Co Adr
15.87 51.34B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.24 41.15B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
34.63 39.67B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
80.24 34.09B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
578.43 24.13B 3.17B 1.29B 1.01B 27.09

Alvotech Stock (ALVO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-09 Eingeleitet Barclays Underweight
2025-11-04 Herabstufung Deutsche Bank Buy → Hold
2025-10-14 Hochstufung Morgan Stanley Equal-Weight → Overweight
2025-09-23 Hochstufung Deutsche Bank Hold → Buy
2025-02-14 Eingeleitet UBS Buy
2024-01-29 Hochstufung Barclays Equal Weight → Overweight
2023-10-20 Hochstufung Citigroup Sell → Neutral
2023-09-21 Eingeleitet Barclays Equal Weight
2022-09-07 Eingeleitet Morgan Stanley Equal-Weight
2022-09-06 Herabstufung Citigroup Buy → Sell
2022-07-26 Eingeleitet Citigroup Buy
Alle ansehen

Alvotech Aktie (ALVO) Neueste Nachrichten

pulisher
May 24, 2026

Alvotech founder Robert Wessman threatens to quit Britain over ‘anti-wealth’ tax regime - Business Matters

May 24, 2026
pulisher
May 21, 2026

Alvotech Earnings Call Balances Setbacks and Momentum - The Globe and Mail

May 21, 2026
pulisher
May 21, 2026

Alvotech plans June FDA resubmissions, sees biosimilar approvals by year-end - MSN

May 21, 2026
pulisher
May 20, 2026

Does Alvotech’s (ALVO) FDA Inspection Outcome Reframe Confidence in Its Biosimilar Strategy for 2026? - simplywall.st

May 20, 2026
pulisher
May 20, 2026

Alvotech stock (LU2557688560): 2026 outlook reaffirmed after earnings call - AD HOC NEWS

May 20, 2026
pulisher
May 20, 2026

Earnings Preview: Alvotech to Report Financial Results on May 06 - 富途牛牛

May 20, 2026
pulisher
May 19, 2026

Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN

May 19, 2026
pulisher
May 18, 2026

Alvotech stock (LU2557688560): latest FDA approval progress and biosimilar pipeline in focus - AD HOC NEWS

May 18, 2026
pulisher
May 17, 2026

Alvotech shares rise as FDA completes Reykjavik facility inspection - MSN

May 17, 2026
pulisher
May 17, 2026

Alvotech faces FDA setback for its Simponi biosimilar AVT05 - MSN

May 17, 2026
pulisher
May 17, 2026

Alvotech (NasdaqGM:ALVO) Valuation Check After FDA Form 483 And Reaffirmed Approval Timelines - simplywall.st

May 17, 2026
pulisher
May 16, 2026

Nordic Stocks Decrease; Alvotech Takes Biggest Hit - 富途牛牛

May 16, 2026
pulisher
May 14, 2026

EBITDA of Alvotech Swedish Depository Receipt Repr 1 Sh – TURQUOISE:ALVOS - TradingView

May 14, 2026
pulisher
May 13, 2026

Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End - MarketBeat

May 13, 2026
pulisher
May 13, 2026

Transcript : Alvotech Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03 - marketscreener.com

May 13, 2026
pulisher
May 13, 2026

Alvotech stock (LU2557688560): Partner Fuji Pharma reports valuation drop - AD HOC NEWS

May 13, 2026
pulisher
May 12, 2026

Alvotech (ALVO) Q1 2026 Earnings Transcript - AOL.com

May 12, 2026
pulisher
May 12, 2026

Alvotech (ALVO) Is Down 7.4% After FDA Form 483 on Key Site Inspection Has The Bull Case Changed? - Sahm

May 12, 2026
pulisher
May 12, 2026

ALVO Stock Price, Quote & Chart | ALVOTECH SA (NASDAQ:ALVO) - ChartMill

May 12, 2026
pulisher
May 11, 2026

Alvotech’s Iceland Manufacturing Facility Passes FDA Surveillance Inspection - geneonline.com

May 11, 2026
pulisher
May 11, 2026

Alvotech Assured After FDA Facility Feedback - Citeline News & Insights

May 11, 2026
pulisher
May 11, 2026

Alvotech Receives US FDA Observations Following Iceland Plant Inspection - Moomoo

May 11, 2026
pulisher
May 11, 2026

Alvotech Clears Key FDA Inspection at Reykjavik Plant, Paving Way for 2026 BLA Resubmissions - TipRanks

May 11, 2026
pulisher
May 11, 2026

Alvotech (NASDAQ: ALVO) reports FDA Form 483 but maintains 2026 BLA approval outlook - Stock Titan

May 11, 2026
pulisher
May 11, 2026

Alvotech advances after FDA wraps Iceland plant inspection - MSN

May 11, 2026
pulisher
May 11, 2026

Alvotech announces cGMP surveillance inspection of Reykjavik facility - TipRanks

May 11, 2026
pulisher
May 11, 2026

FDA completes inspection at Alvotech's Reykjavik facility; company on track for BLA resubmissions this quarter - Pluang

May 11, 2026
pulisher
May 11, 2026

Alvotech announces completion of FDA surveillance inspection at Reykjavik facility - The Manila Times

May 11, 2026
pulisher
May 11, 2026

Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility - The Manila Times

May 11, 2026
pulisher
May 11, 2026

FDA issues Form 483 at Iceland plant; Alvotech still targets 2026 drug approvals - Stock Titan

May 11, 2026
pulisher
May 11, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 11, 2026
pulisher
May 10, 2026

Alvotech reports completion of FDA inspection in Iceland - grafa.com

May 10, 2026
pulisher
May 10, 2026

Alvotech stock (LU2557688560): Q1 2026 revenue dip and EBITDA rise on mix shift - AD HOC NEWS

May 10, 2026
pulisher
May 10, 2026

Dr Reddy's Share Price: Hits ₹1,303.4 On June 5 After $29.5B Keytruda Biosimilar Deal With Alvotech (x8QfRltOd3) - Fathom Journal

May 10, 2026
pulisher
May 09, 2026

Alvotech Earnings Call Balances Risk and Growth - The Globe and Mail

May 09, 2026
pulisher
May 09, 2026

A Look At Alvotech (NasdaqGM:ALVO) Valuation After Weak Q1 2026 Results And Biosimilar Pipeline Updates - simplywall.st

May 09, 2026
pulisher
May 08, 2026

ALVOW (Alvotech) warrants remain flat as quarterly earnings data not disclosed to markets.Current Ratio - newser.com

May 08, 2026
pulisher
May 08, 2026

Nordic Shares Decline; Alvotech Posts Biggest Loss - Moomoo

May 08, 2026
pulisher
May 08, 2026

Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift - Investing.com Canada

May 08, 2026
pulisher
May 08, 2026

Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift By Investing.com - Investing.com South Africa

May 08, 2026
pulisher
May 07, 2026

Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips - Investing.com UK

May 07, 2026
pulisher
May 07, 2026

Alvotech’s Earnings Swing And Counsel Exit Might Change The Case For Investing In ALVO - Yahoo Finance

May 07, 2026
pulisher
May 07, 2026

Alvotech (NASDAQ:ALVO) Shares Gap DownTime to Sell? - MarketBeat

May 07, 2026
pulisher
May 07, 2026

Alvotech Q1 2026 Financial Results - Sahm

May 07, 2026
pulisher
May 07, 2026

Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips By Investing.com - Investing.com South Africa

May 07, 2026
pulisher
May 07, 2026

Alvotech Q1 Earnings Call Highlights - MarketBeat

May 07, 2026

Finanzdaten der Alvotech-Aktie (ALVO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.84
price up icon 5.13%
RDY RDY
$13.76
price up icon 1.29%
RGC RGC
$24.20
price down icon 6.20%
$155.77
price down icon 0.52%
$16.26
price down icon 2.49%
$578.43
price up icon 1.49%
Kapitalisierung:     |  Volumen (24h):